Tests and Diagnosis of Liver Cancer
According to the PDQ Adult Treatment board, patients with large liver lesions more than 1cm in diameter who are also at risk for HCC should undergo testing involving imaging, biopsy or both in order to generate a proper diagnosis. Lesions smaller than 1cm in high-risk patients will be closely monitored, but will not undergo further testing for diagnosis since it is likely a cirrhotic lesion. There are many negative predictors of survival from liver cancer. These include vascular invasion, or when the cancer cells escape into the blood vessels, fibrosis or the formation of excess connective tissue in an organ (in this case the liver) and cirrhosis. Tumor size is also a negative predictor. Imaging : Lesions are imaged using either triple-phase, contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI). Using CT or MRI, the liver is imaged in two different phases; the arterial phase and the venous phase. Prior to imaging, a contrast media is injected into the patient’s veins to enhance the contrast of various structures in the different phases. Because HCCs only contain blood from the arteries while the rest of the liver has arteries and veins, the contrast media is more highly concentrated in the HCC.